GNLX: Genelux Corp Company Profile & Statistics

About

Genelux Corporation is a clinical-stage biopharmaceutical company. It focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company's most advanced product candidate, Olvi-Vec, is a proprietary, modified strain of the vaccinia virus, a stable DNA virus. Genelux Corporation is based in WESTLAKE VILLAGE, Calif.

Info & Links

CEO

Thomas Zindrick

Headquarters

2625 Townsgate Road Suite 230
Westlake Village, CA 91361, UNITED STATES

Auditor

Weinberg & Company, P.A.

Share holders

1,101

Employees

Genelux Corp Statistics

Valuation Measures

Market Capitalization²

80.13M

Enterprise Value

74.03M

Enterprise Value/EBITDA(ttm)

-2.53

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

2.43

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

-24531.25%

Return on Equity(ttm)

-105.05%

Return on Invested Capital(ttm)

-123.79%

Return on Assets(ttm)

-80.16%

Income Statement

Revenue(ttm)

8.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

8.00K

EBITDA(ttm)³

-29.29M

Net Income Available to Common(ttm)

-27.66M

Diluted EPS(ttm)

-0.95

Share Statistics

Beta (5Y Monthly)

-2.05

52-Week Change

-82.94%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

34.54M

Dividend Yield

0.00%

Float⁴

31.33M

% Held by Insiders

9.30%

% Held by Institutions

37.33%

Balance Sheet

Total Cash(mrq)

34.06M

Total Cash Per Share(mrq)

0.99

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.47%

Quick Ratio(mrq)

6.47%

Book Value Per Share(mrq)

0.96

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.49

Free Cash Flow(ytd)

-17.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

GNLX

Genelux Corp

Genelux Corp Profile